| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,232,000 | 2,336,000 | 2,668,000 | 3,186,500 | | Cost of Revenue | 1,761,000 | 1,797,000 | 1,960,000 | 2,160,200 | | | Gross Profit | 471,000 | 539,000 | 708,000 | 1,026,300 | | | Operating Expenses | | Research Development | 88,000 | 102,000 | 109,000 | 114,100 | | Selling General and Administrative | 272,000 | 284,000 | 281,000 | 247,400 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 111,000 | 153,000 | 318,000 | 664,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 3,000 | 1,000 | (20,300) | | Earnings Before Interest And Taxes | 112,000 | 156,000 | 319,000 | 645,000 | | Interest Expense | 29,000 | 34,000 | 35,000 | 35,700 | | Income Before Tax | 83,000 | 122,000 | 284,000 | 609,300 | | Income Tax Expense | 28,000 | 35,000 | 89,000 | 177,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 55,000 | 87,000 | 195,000 | 431,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 55,000 | 87,000 | 195,000 | 431,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $55,000 | $87,000 | $195,000 | $431,800 |
|
0.01% Nasdaq 0.00%
Income Statement
